Author name: EuMe-adm

With effect of January 2024, Swissmedic has started with a reorganisation in order to distinct more clear intern responsibilities regarding market surveillance and medical devices. The new department Medical Device Surveillance is responsible for safety of clinical trials, materiovigilance and market monitoring of medical devices. See more infos on Swissmedic website.

The Benefits of Integrating an Information Security Management System to Medical Device Manufacturers   Medical device manufacturers face unique challenges when it comes to ensuring the security and privacy of sensitive information such as clinical data or intellectual property of design development. With the increasing prevalence of cyber threats and the need to comply with

Understanding EUDAMED – A Key Resource for Medical Device Registration in the EU In the vast landscape of medical devices, one may wonder how regulators manage the enormous amount of information related to manufacturers, product details, safety reports, and clinical trials. The answer, for those operating in the European Union (EU), is a robust, secure

Medical Device Authorized Representative:   What is an Authorized Representative: An authorized representative in the medical device industry refers to a legal entity or an individual that acts on behalf of a manufacturer in dealing with regulatory authorities. Their role is to facilitate the manufacturer’s compliance with legislation in the country or region where the

Swissmedic has performed inspections at class 1 manufacturers within Switzerland. The result is impressive, but not surprising due to our experience as Authorised Representative in EU, Switzerland and UK. During our onboarding process EUMEDIQ, we check not only completeness of Technical Documentation of our customer, we also do a plausibility check in order to estimate

In December 2022, the European Commission published the new directive (EU) 2022/2555 on measures for a common level of cybersecurity across the Union. This led to the amendment of the regulation (EU) 910/2014 on electronic identification and trust services for electronic transactions in the internal market (also known as eIDAS regulation) and repeals the NIS